Molecular effects of chemotherapeutic drugs and their modulation by antioxidants in the testis

European Journal of Pharmacology

Volumn 674, Issue 2-3, 2012, Pages 207-216

  Narayana, Kilarkaje ^a   Al Bader, Maie ^a   Mousa, Alyaa ^a   Khan, Khalid M ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Antioxidant; Bax; Bcl 2; Cancer chemotherapy; Germ cell apoptosis; Gonadotoxicity; Oxidative stress; p53

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BLEOMYCIN; CISPLATIN; ETOPOSIDE; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; SELENIUM; ZINC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL DEGENERATION; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; GENE EXPRESSION; GERM CELL; LIPID PEROXIDATION; MALE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEMINIFEROUS TUBULE EPITHELIUM; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY; TESTIS; TESTIS WEIGHT; UPREGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BCL-2-ASSOCIATED X PROTEIN; CELL DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; MALE; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCTION; SPERMATOZOA; TESTIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84855538160     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.11.025     Document Type: Article

References (60)

1. Agarwal, A., Prabhakaran, S.A., Said, T.M., 2005. Prevention of oxidative stress injury to sperm. J. Androl. 26, 654-660. (Pubitemid 41476621)
2. Al-Bader, M.D., El-Abdallahb, A.A., Redzic, Z.B., 2008. Ontogenic profile of estrogen receptor alpha and beta mRNA and protein expression in fetal rat brain. Neurosci. Lett. 440, 222-226.
3. Amin, A., Hamza, A.A., 2006. Effects of Roselle and Ginger on cisplatin-induced reproductive toxicity in rats. Asian J. Androl. 8 (5), 607-612. (Pubitemid 44263435)
4. Atessahin, A., Karahan, I., Turk, G., Gur, S., Yilmaz, S., Ceribasi, A.O., 2006a. Protective role of lycopene on cisplatin-induced changes in sperm characteristics, testicular damage and oxidative stress in rats. Reprod. Toxicol. 21, 42-47. (Pubitemid 43048773)
5. Atessahin, A., Sahna, E., Gaffari, T., Ceribas, A.O., Yilmaz, S., Yuce, A., Bulmus, O., 2006b. Chemoprotective effect of melatonin against cisplatin-induced testicular toxicity in rats. J. Pineal Res. 41, 21-27. (Pubitemid 43980691)
6. Awasthi, Y.C., Yang, Y., Tiwari, N.K., Patrick, B., Sharma, A., Li, J., Awasthi, S., 2004. Regulation of 4-hydroxynonenal-mediated signaling by glutathione S-transferases. Free Radic. Biol. Med. 37, 607-619. (Pubitemid 38993509)
7. Bai, J., Meng, Z., 2005. Expression of apoptosis-related genes in livers from rats exposed to sulfur dioxide. Toxicology 216, 253-260. (Pubitemid 41712014)
8. Bancroft, J.D., Stevens, A., 1990. Theory and Practice of Histological Techniques, 3rd Edition. Churchill Livingstone, London, pp. 133-134.
9. Basu, A., Haldar, S., 1998. The relationship between Bcl-2, Bax and p53: consequences for cell cycle progression and cell death. Mol. Hum. Reprod. 4, 1099-1109. (Pubitemid 28552792)
10. Bieber, A.M., Marcon, L., Hales, B.F., Robaire, B., 2006. Effects of chemotherapeutic agents for testicular cancer on the male rat reproductive system, spermatozoa, and fertility. J. Androl. 27, 189-200.
11. Castellini, C., Mourvaki, E., Dal Bosco, A., Galli, F., 2007. Vitamin E biochemistry and function: a case study in male rabbit. Reprod. Domest. Anim. 42, 248-256. (Pubitemid 46763492)
12. Chang, S.I., Jin, B., Youn, P., Park, C., Park, J.D., Ryu, D.Y., 2007. Arsenic-induced toxicity and the protective role of ascorbic acid in mouse testis. Toxicol. Appl. Pharmacol. 218, 196-203. (Pubitemid 46177170)
13. Delbes, G., Hales, B.F., Robaire, B., 2007. Effects of the chemotherapy cocktail used to treat testicular cancer on sperm chromatin integrity. J. Androl. 28, 241-249. (Pubitemid 46423905)
14. Delbes, G., Chan, D., Pakarinen, P., Trasler, J.M., Hales, B.F., Robaire, B., 2009. Impact of the chemotherapy cocktail used to treat testicular cancer on the gene expression profile of germ cells from male Brown-Norway rats. Biol. Reprod. 80, 320-327.
15. Elchuri, S., Oberley, T.D., Qi, W., Eisenstein, R.S., Jackson Roberts, L., Van Remmen, H., Epstein, C.J., Huang, T.T., 2005. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 24, 367-380. (Pubitemid 40188585)
16. Eun, J.R., Lee, H.J., Moon, H.J., Kim, T.N., Kim, J.W., Chang, J.C., 2009. Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-alpha for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis. Scand. J. Gastroenterol. 44, 1477-1486.
17. Fetoni, A.R., Sergi, B., Ferraresi, A., Paludetti, G., Troiani, D., 2004. Protective effects of alpha-tocopherol and tiopronin against cisplatin-induced ototoxicity. Acta Otolaryngol. 124, 421-426. (Pubitemid 38797598)
18. Gold, R., Schmied, M., Giegerich, G., Breitschopf, H., Hartung, H.P., Toyka, K.V., Lassmann, H., 1994. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab. Invest. 71, 219-225. (Pubitemid 24278174)
19. Hershberger, P.A., McGuire, T.F., Yu, W.D., Zuhowski, E.G., Schellens, J.H., Egorin, M.J., Trump, D.L., Johnson, C.S., 2002. Cisplatin potentiates 1,25-dihydroxyvitamin D3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression. Mol. Cancer Ther. 1, 821-829.
20. Hoshino, T., Okamoto, M., Sakazaki, Y., Kato, S., Young, H.A., Aizawa, H., 2009. Role of proinflammatory cytokines IL-18 and IL-1 beta in bleomycin-induced lung injury in humans and mice. Am. J. Respir. Cell Mol. Biol. 41, 661-670.
21. Howell, S.J., Shalet, S.M., 2001. Testicular function following chemotherapy. Hum. Reprod. Update 7, 363-369. (Pubitemid 32655321)
22. Howell, S.J., Shalet, S.M., 2002. Effect of cancer chemotherapy on pituitary-testicular axis. Int. J. Androl. 25, 269-276.
23. Ilbey, Y.O., Ozbek, E., Simsek, A., Otunctemur, A., Cekmen, M., Somay, A., 2009. Potential chemoprotective effect of melatonin in cyclophosphamide- and cisplatin-induced testicular damage in rats. Fertil. Steril. 92, 1124-1132.
24. Kanvah, S., Joseph, J., Schuster, G.B., Barnett, R.N., Cleveland, C.L., Landman, U., 2010. Oxidation of DNA damage to nucleobases. Acc. Chem. Res. 43, 280-287.
25. Kasenda, B., Harter, P., Hirsch, T., Ast, A., Buhrmann, C., Glaser, F., Du Bois, A., 2009. Para-aortic lymph node metastasis in malignant dysgerminoma of the ovary. Acta Obstet. Gynecol. Scand. 88, 1288-1290.
26. Kawai, K., Akaza, H., 2010. Current status of chemotherapy in risk-adapted management for metastatic testicular germ cell cancer. Cancer Sci. 101, 22-28.
27. Koc, A., Duru, M., Ciralik, H., Akcan, R., Sogut, S., 2005. Protective agent, erdosteine, against cisplatin-induced hepatic oxidant injury in rats. Mol. Cell. Biochem. 278, 79-84. (Pubitemid 41418922)
28. Kutuk, O., Poli, G., Basaga, H., 2006. Resveratrol protects against 4-hydroxynonenal-induced apoptosis by blocking JNK and c-JUN/AP-1 signaling. Toxicol. Sci. 90, 120-132. (Pubitemid 43264732)
29. Latchoumycandane, C., Chitra, K.C., Mathur, P.P., 2002. The effect of methoxychlor on the epididymal antioxidant system of adult rats. Reprod. Toxicol. 16, 161-172. (Pubitemid 34457188)
30. Lee, Y.H., Park, E.K., Park, Y.S., Shim, K.W., Choi, J.U., Kim, D.S., 2009. Treatment and outcomes of primary intracranial teratoma. Child. Nerv. Syst. 25, 1581-1587.
31. Leonetti, C., Biroccio, A., Gabellini, C., Scarsella, M., Maresca, V., Flori, E., Bove, L., Pace, A., Stoppacciaro, A., Zupi, G., Cognetti, F., Picardo, M., 2003. a-Tocopherol protects against cisplatin-induced toxicity without interfering with antitumor efficacy. Int. J. Cancer 104, 243-250. (Pubitemid 36249802)
32. Li, G.Y., Xie, P., Li, H.Y., Hao, L., Xiong, Q., Qiu, T., 2011. Involvement of p53, Bax and Bcl-2 pathway in microcystins-induced apoptosis in rat testis. Environ. Toxicol. 26, 111-117.
33. Maliakel, D.M., Kagiya, T.V., Nair, C.K., 2008. Prevention of cisplatin-induced nephrotoxicity by glucosides of ascorbic acid and alpha-tocopherol. Exp. Toxicol. Pathol. 60, 521-527.
34. Marcon, L., Hales, B.F., Robaire, B., 2008. Reversibility of the effects of subchronic exposure to cancer chemotherapeutics, bleomycin, etoposide and cisplatin (BEP), on spermatogenesis, fertility and progeny outcome in the male rat. J. Androl. 29, 408-417. (Pubitemid 351929926)
35. Marnett, J., 1999. Lipid peroxidation-DNA damage by malondialdehyde. Mutat. Res. 424, 83-95.
36. Narayana, K., 2008. An aminoglycoside antibiotic gentamycin induces oxidative stress, reduces antioxidant reserve and impairs spermatogenesis in rats. J. Toxicol. Sci. 33, 85-96. (Pubitemid 351340766)
37. Narayana, K., Verghese, S., Jacob, S.S., 2009. L-Ascorbic acid partially protects two cycles of cisplatin chemotherapy-induced testis damage and oligo-asthenoteratospermia in a mouse model. Exp. Toxicol. Pathol. 61, 5535-5563.
38. Ohkawa, H., Ohishi, N., Yagi, K., 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 551-558.
39. Paglia, D.E., Valentine, W.N., 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70, 158-169.
40. Poorman-Allen, P., Backer, L.C., Adler, D., Westbrook-Collins, B., Moscs, M.J., Allen, J.W., 1990. Bleomycin effects on mouse meiotic chromosomes. Mutagenesis 5, 573-581. (Pubitemid 20386561)
41. Quinn, P.J., 2007. Molecular associations of alfa-tocopherol. Vitam. Horm. 76, 67-98.
42. Russell, L.B., Hunsicker, P.R., Kerley, M.K., Johnson, D.K., Shelby, M.D., 2000. Bleomycin, unlike other male-mouse mutagens, is most effective in spermatogonia, inducing primarily deletions. Mutat. Res. 469, 95-105. (Pubitemid 30628678)
43. Sawhney, P., Giammona, C.J., Meistrich, M.L., Richburg, J.H., 2005. Cisplatin-induced long-term failure of spermatogenesis in adult C57/Bl/6J mice. J. Androl. 26, 136-145. (Pubitemid 39665287)
44. Seema, P., Swathy, S.S., Indira, M., 2007. Protective effect of selenium on nicotine-induced testicular toxicity in rats. Biol. Trace Elem. Res. 120, 212-218. (Pubitemid 350085228)
45. Sleijfer, S., 2001. Bleomycin-induced pneumonitis. Chest 120, 617-624. (Pubitemid 32881285)
46. Song, G.J., Norkus, E.P., Lewis, V., 2006. Relationship between seminal ascorbic acid and sperm DNA integrity in infertile men. Int. J. Androl. 29, 569-575. (Pubitemid 44800234)
47. Spermon, J.R., Ramos, L., Wetzels, A.M., Sweep, C.G., Braat, D.D., Kiemeney, L.A., Witjes, J.A., 2006. Sperm integrity pre- and post-chemotherapy in men with testicular germ cell cancer. Hum. Reprod. 21, 1781-1786. (Pubitemid 44028250)
48. Steinmann, D., Cerny, B., Karstens, J.H., Bremer, M., 2009. Chemoradiotherapy with weekly cisplatin 40 mg/m(2) in 103 head-and-neck cancer patients: a cumulative dose-effect analysis. Strahlenther. Onkol. 185, 682-688.
49. Stumpp, T., Freymüller, E., Miraglia, S.M., 2006. Sertoli cell function in albino rats treated with etoposide during prepubertal phase. Histochem. Cell Biol. 126, 353-361.
50. Tribius, S., Kronemann, S., Kilic, Y., Schroeder, U., Hakim, S., Schild, S.E., Rades, D., 2009. Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck. Strahlenther. Onkol. 185, 675-681.
51. Turk, G., Ateşşahin, A., Sönmez, M., Ceribaşi, A.O., Yüce, A., 2008. Improvement of cisplatin-induced injuries to sperm quality, the oxidant-antioxidant system, and the histologic structure of the rat testis by ellagic acid. Fertil. Steril. 89, 1474-1481. (Pubitemid 351680100)
52. Turner, T.T., Lysiak, J.J., 2008. Oxidative stress: a common factor in testicular dysfunction. J. Androl. 29, 488-498.
53. Usuda, K., Sagawa, M., Aikawa, H., Ueno, M., Tanaka, M., Machida, Y., Tsuchihara, K., Masaki, Y., Kinoshita, E., Sakuma, T., 2009. Complete resection of an advanced mediastinal nonseminomatous germ cell tumor with multiple distant metastases after down-staging by chemotherapy. Kyobu Geka 62, 545-551.
54. WHO, 2003. Manual of Basic Techniques for a Health Laboratory, 2nd edition., pp. 288-291.
55. Woo, H.Y., Bae, S.H., Park, J.Y., Han, K.H., Chun, H.J., Choi, B.G., Im, H.U., Choi, J.Y., Yoon, S.K., Cheong, J.Y., Cho, S.W., Jang, B.K., Hwang, J.S., Kim, S.G., Kim, Y.S., Seo, Y.S., Yim, H.J., Um, S.H., Korean Liver Cancer Study Group, 2010. A randomized comparative study of high-dose and low-dose hepatic arterial infusion chemotherapy for intractable, advanced hepatocellular carcinoma. Cancer Chemother. Pharmacol. 65, 373-382.
56. Wozniak, K., Blasiak, J., 2002. Recognition and repair of DNA-cisplatin adducts. Acta Biochim. Pol. 49, 583-596. (Pubitemid 135700585)
57. Xu, J., Lian, L.J., Wu, C., Wang, X.F., Fu, W.Y., Xu, L.H., 2008. Lead induces oxidative stress, DNA damage and alteration of p53, Bax and Bcl-2 expressions in mice. Food Chem. Toxicol. 46, 1488-1494.
58. Yoo, S.C., Kim, W.Y., Yoon, J.H., Chang, S.J., Chang, K.H., Ryu, H.S., 2010. Young girls with malignant ovarian germ cell tumors can undergo normal menarche and menstruation after fertility-preserving surgery and adjuvant chemotherapy. Acta Obstet. Gynecol. Scand. 89, 126-130.
59. Zegura, B., Zajc, I., Lah, T.T., Filipic, M., 2008. Patterns of microcystin-LR induced alteration of the expression of genes involved in response to DNA damage and apoptosis. Toxicon 51, 615-623.
60. Zhao, Y., Chen, X.-g., Du, J.-z., 2009. Cellular adaptation to hypoxia and p53 transcription regulation. J. Zhejiang Univ. Sci. B 10, 404-410.